The AB series oil free screw air compressors manufactured by Elgi Equipments Ltd have gained significant acceptance in the pharmaceutical industry. Coupled with corrosion resistant SS rotors, compact air-cooled package, low noise, and lower maintenance cost it offers the safest pneumatic air for the sectors sensitive, critical processes.

The Indian pharmaceutical industry is estimated to grow at 22.4% yearly, to US $100 billion by 2025. In this backdrop Dr Jairam Varadaraj, Managing Director, Elgi Equipments Ltd said, “In light of the pandemic, India’s pharmaceutical industry has a tremendous opportunity to play a pivotal role in global healthcare. With growing FDA scrutiny, strict warnings over toxic impurities and delicate pharmaceutical manufacturing processes, the quality of compressed air meeting the highest standards, is of quintessential importance. On the other hand, continuous air supply must be guaranteed since a disruption can lead to an immense loss of production. At ELGi, we endeavoured to address the needs of the pharmaceutical manufacturing industry in a new way. The ELGi AB ‘Always Better’ series is a disruption in oil free compressed air technology, and we’re delighted to witness its growing adoption as the customer’s choice for sensitive pharmaceutical applications.” elaborated.

Added to this Rajesh Premchandran, Director, ISAAME (India, South Asia, Africa and Middle East), Elgi Equipments Ltd, “The AB Series is a disruption in oil free compressed air technology, offering pharmaceutical customers a no-compromise, oil free solution at reduced lifecycle costs when compared with prevailing oil free technologies. With the AB Series compressors, pharmaceutical installations get the purest form of compressed air with higher efficiency, increased eliability and quicker return on investment.”

For more information: www.elgi.com